glp-1 drug companies The Next Big Weight Loss Stocks The New York Times spotlighted

[DOI] [PMC free article] [PubMed] [Google Scholar] 131.Tang S.T., Zhang Q., Tang H.Q., Wang C.J., Su H., Zhou Q

Selley and colleagues reported that GLP-1 associated vasodilation was mediated through the glucagon receptor [63]

Consequently, this promotes fundic relaxation, decreases peristalsis in the gastric antrum and duodenum, and increases pyloric sphincter tone, thereby delaying the transfer of gastric contents into the duodenum [29]

Interestingly, this connection between peripheral and central GLP-1 secretion may play a significant role in GLP-1 enhancement of the insulin response

The impact on weight accumulates while the drug is titrated to a maintenance dose, occurring every four weeks in these studies